glp-1 weight loss drug news november 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford When Joshua Hunt (@viajoshhunt) started

She had been asked to help validate Millipore's new instrument based on ion exchange high-performance liquid chromatography

By reducing hunger [38] and attenuating reward responsivity [39], GLP-1 RAs may create a temporary low-drive window during which behavioral change becomes more achievable

Billings, MD, MMSc Billings is the lead author of a Phase 2 clinical trial recently published in the journal Eloralintide is the name of the new medication produced by Eli Lilly and Company that is focused on in this clinical trial

A 2024 Cornell University study found that households with at least one GLP-1 user reduced grocery spending by 5.3% within six months of starting treatment (CNBC, 2025)

Roughly 63% of participants on the highest dose achieved at least 20% weight loss, and about 40% achieved 25% or more